Active Targeting of P-Selectin by Fucoidan Modulates the Molecular Profiling of Metastasis in Docetaxel-Resistant Prostate Cancer

The standard of care for prostate cancer (PCa) is androgen deprivation therapy (ADT). Although hormone-sensitive PCa is curable by ADT, most conditions progress to castration-resistant prostate cancer (CRPCa) and metastatic CRPCa (mCRPCa). Front-line docetaxel has been administered to patients with...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Chang-Hsun Ho, Mei-Lin Chen, Hau-Lun Huang, Chih-Jen Lai, Chih-Hsin Liu, Chih-Pin Chuu, Yu-Hsin Lin
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2022-08-01
Serie:	Marine Drugs
Soggetti:	prostate cancer docetaxel resistant fucoidan metastasis-inhibiting signaling pathway synergistic effects
Accesso online:	https://www.mdpi.com/1660-3397/20/9/542
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!